PIPELINE
Programs
Discovery
Lead
Optimization
Preclinical Development
Phase 1a
Phase 1b/2a
Late Stage

SIR0365

SIR0365

SIR0365

SIR2446

SIR1X

RIPK1
COVID-19 severe hyperinflammation
Ph1b patient study
Bridging PK study
Ph1a healthy subjects
SIR2
SIR3
SIR4
SIR5
SIR6(Biologics)
SIR7(Biologics)
横向移动